27
Sep 2019
‘Revolutionary’ new tumour-agnostic cancer drugs approved for use
A ‘revolutionary’ new cancer drug which is able to treat a wide range of tumours has been approved for the first time for use across Europe. The new tumour-agnostic drugs target any tumours within the body that have a specific genetic abnormality inside, regardless of where the cancer is growing in the body. UK doctors…